Non-small cell lung cancer (NSCLC) is among the leading causes of human mortality. One reason for high rates of NSCLC mortality is that drug resistance is a major problem for both conventional chemotherapies and less-toxic targeted therapies. Thus, novel mechanistic insights into disease pathogenesis may benefit the development of urgently needed therapies. Here we show that FBJ murine osteosarcoma viral oncogene homolog B (FOSB) was induced by an antimicrobial peptide, tilapia piscidin-4 (TP4), through the dysregulation of mitochondrial Ca 2+ homeostasis in NSCLC cells. Transcriptomic, chromatin immunoprecipitation quantitative PCR, and immunocytochemical studies reveal that protocadherin-β13 (PCDHB13) as a target of FOSB that was functionally associated with microtubule. Overexpression of either PCDHB13 or FOSB attenuated NSCLC growth and survival in vitro and in vivo. Importantly, downregulation of both FOSB and PCDHB13 was observed in NSCLC patients and was negatively correlated with pathological grade. These findings introduce the FOSB-PCDHB13 axis as a novel tumor suppressive pathway in NSCLC.

Original languageEnglish
Article number107
Issue number1
Publication statusPublished - Jan 1 2019


  • antimicrobial peptide
  • Cytoskeleton
  • FOSB
  • Mitochondrial stress
  • Non-small cell lung cancer (NSCLC)
  • Protocadherin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'FOSB-PCDHB13 axis disrupts the microtubule network in non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this